Multicenter Trial For Patients With Acute Crohn's Disease
1 other identifier
interventional
N/A
2 countries
11
Brief Summary
The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2002
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2002
CompletedFirst Submitted
Initial submission to the registry
May 3, 2002
CompletedFirst Posted
Study publicly available on registry
May 6, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2004
CompletedDecember 8, 2021
December 1, 2021
2 years
May 3, 2002
December 1, 2021
Conditions
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (11)
Stuart Weisman
Palo Alto, California, 94304, United States
University of Colorado Medical Center
Denver, Colorado, 80262, United States
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Mark Lamet
Hollywood, Florida, 33021, United States
Wayne Schonfeld
Hollywood, Florida, 33021, United States
Mount Sinai Medical Center
Miami Beach, Florida, 33140, United States
University of Chicago Hospital Medical Center
Chicago, Illinois, 60637, United States
Gerald Dryden
Louisville, Kentucky, 40202, United States
Richard MacDermott
Albany, New York, 12208, United States
Hillary Steinhart
Toronto, Ontario, M5G 1XB, Canada
Gary Wild
Montreal, Quebec, H3G 1A4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2002
First Posted
May 6, 2002
Study Start
January 31, 2002
Primary Completion
January 31, 2004
Study Completion
January 31, 2004
Last Updated
December 8, 2021
Record last verified: 2021-12